Navigation Links
Global Biopharmaceuticals Market 2011-2015
Date:7/23/2012

NEW YORK, July 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Biopharmaceuticals Market 2011-2015

http://www.reportlinker.com/p0936096/Global-Biopharmaceuticals-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Pfizer Inc., Abbott Laboratories Inc., Sanofi S.A., AstraZeneca plc, and Johnson and Johnson Services Inc. Other vendors in the market are GlaxoSmithKline plc, Merck Sereno S.A., UCB S.A., and Boehringer Ingelheim GmbH.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by e
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DARTâ„¢ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015 ... company developing novel biological drugs to treat cancer, ... to announce the appointment of Christina Coughlin ... be responsible for providing medical and regulatory leadership ... Company. Dr. Coughlin has extensive experience ...
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ - ESSA Pharma ... that it has filed with the Food and Drug ... ("IND") application related to the Company,s proposed clinical trial ... IND application is required in order for ESSA to ... The IND application is a complete description ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Pittcon 2015, ... Applied Spectroscopy, ended on March 12, in New Orleans ... $21 million as estimated by the New Orleans Convention ... than 14,200 conferees and exhibitor personnel. Those who ... the conferee number. For the third year, the co-location ...
(Date:3/31/2015)... 31, 2015   Mapi expands Pharmacovigilance ... Affairs and global Risk Management strength with the ... announced acquisition . Pharmacovigilance ... a global team that includes physicians, pharmacists, and ... experience in navigating complex safety requirements throughout the ...
Breaking Biology Technology:Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Pittcon 2015 Hits the Big Easy in a Big Way 2Pittcon 2015 Hits the Big Easy in a Big Way 3Pittcon 2015 Hits the Big Easy in a Big Way 4Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3
... has found that a currently available yet underused vaccine against ... unvaccinated neighbors of vaccinees. The study, conducted by ... Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India, ... New England Journal of Medicine (NEJM). The IVI, based ...
... , LYNBROOK, N.Y., July 22 BioSpecifics Technologies ... in class collagenase-based products, today announced that BioSpecifics, President, Tom Wegman, ... Conference on Wednesday, July 29, 2009, at 9:30am CT at the ... A live webcast of the presentation can be accessed under ...
... July 22 Sirnaomics, Inc. (www.sirnaomics.com) announced today ... business innovation research) grant from National Cancer Institute ... novel siRNA therapeutics to treat lung cancer. Sirnaomics, ... is dedicated to advancing RNA interference (RNAi) Technology ...
Cached Biology Technology:Vi typhoid vaccine proves highly effective in young children 2Vi typhoid vaccine proves highly effective in young children 3Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 3
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... grow replacement bones with stem cell technology, thanks to research ... Many scientists are currently trying to create bone-like materials, ... damaged or fractured bones, or who have had parts of ... materials could be inserted into cavities so that real bone ...
... WASHINGTON, DC U.S. Secretary of Energy Steven ... 46 of the 100 awards given out this year ... with promising commercial potential. The coveted awards are ... materials or software developed throughout the world and introduced ...
... bad-tasting and potentially poisonous foods may also play a role ... study by scientists at the University of Iowa Roy J. ... help explain why injured lungs are susceptible to further damage. ... Express, shows that receptors for bitter compounds that are ...
Cached Biology News:Scientists closer to making implantable bone material, thanks to new research 2DOE-funded research projects win 46 R&D 100 Awards for 2009 2DOE-funded research projects win 46 R&D 100 Awards for 2009 3DOE-funded research projects win 46 R&D 100 Awards for 2009 4DOE-funded research projects win 46 R&D 100 Awards for 2009 5DOE-funded research projects win 46 R&D 100 Awards for 2009 6DOE-funded research projects win 46 R&D 100 Awards for 2009 7DOE-funded research projects win 46 R&D 100 Awards for 2009 8DOE-funded research projects win 46 R&D 100 Awards for 2009 9DOE-funded research projects win 46 R&D 100 Awards for 2009 10DOE-funded research projects win 46 R&D 100 Awards for 2009 11DOE-funded research projects win 46 R&D 100 Awards for 2009 12DOE-funded research projects win 46 R&D 100 Awards for 2009 13DOE-funded research projects win 46 R&D 100 Awards for 2009 14Airway cells use 'tasting' mechanism to detect and clear harmful substances 2
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody...
... Rabbit polyclonal to SARA ( Abpromise ... Antigen: Synthetic peptide: PVPKEMEQPV QTEEEDVELP ... 281-300 of Fruit fly (Drosophila melanogaster) SARA. ... Entrez Gene ID: 9372 ...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: